Position in AVLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,837,873
New position
Shares Held
3,883,289
first reported quarter
Ownership
8.76%
of shares outstanding
% of Portfolio
7.45%
of 13F equity value
Holder Rank
#2
of 92 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOVO HOLDINGS A/S holds $1,241,938,796 across 18 Biotechnology names. AVLN ranks #5 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
5,350,000 | $217,370,500 | |
| 2 | COAG |
Hemab Therapeutics Holdings, Inc.
|
4,180,550 | $153,551,601 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $132,128,532 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,125,000 | $131,703,750 | |
| 5 | AVLN |
Avalyn Pharma Inc.
This page
|
3,883,289 | $127,837,873 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,500,000 | $52,110,000 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
1,000,000 | $50,750,000 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,320,000 | $49,394,400 |
All Filings in AVLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,837,873 | 3,883,289 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $127,837,873 | 3,883,289 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||